About the Event

The MTPConnect Adelaide Intermediary Program Hub invites you to join the monthly SA Insights Series

About this event

Jo Close, Director of the Adelaide Intermediary Program, will facilitate a conversation with Biome Bank’s Thomas Mitchell (CEO) and Sam Costello (Co-Founder and Chief Medical Officer).

During this fire-side style chat you will discover Sam’s journey from clinician at the Queen Elizabeth Hospital to entrepreneur of a start-up. Sam and Thomas will share the challenges of developing the world’s first regulated microbial therapy, secrets to a successful start-up and the future vision for this exciting South Australian company.

Duration: Two hours

This event will be followed by an opportunity to network over drinks and nibbles.

Who should attend:

Researchers, clinicians, entrepreneurs, founders, MTP industry professionals, commercialisation professionals.

Speakers:

About Biome Bank:

Established in 2018, BiomeBank is a rapidly expanding South Australian biotech with its sights on revolutionising treatments for a range of diseases by restoring gut microbial ecology.

Their first drug product, BIOMICTRA, is a donor derived microbiome-based therapy manufactured locally and supplied throughout Australia to treat a severe gut infection and a chronic disease. However, their multidisciplinary approach to development and their pipeline of innovative microbial therapies is set to transform the global microbial therapy landscape.

Parking:

Please note nearest car parking is available at the Royal Adelaide Hospital and Adelaide Convention Centre.

Further Information:

Click here to REGISTER.

For more information, please contact Engagement and Communications Manager Pia Vogrin on pia.vogrin@mtpconnect.org.au or 0419 853 614.

---